BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akkın S, Varan G, Bilensoy E. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules 2021;26:3382. [PMID: 34205019 DOI: 10.3390/molecules26113382] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Akkın S, Varan G, Işık A, Gökşen S, Karakoç E, Malanga M, Esendağlı G, Korkusuz P, Bilensoy E. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer. Pharmaceutics 2023;15:314. [DOI: 10.3390/pharmaceutics15020314] [Reference Citation Analysis]
2 Javier GC, Alberto I, Azucena GNE, Iván V, Débora M, David P, Laura A, Andrea MS, Esther S, Oleguer C, Paula B, Laura M, Nuria V, Miquel N, Patricia G, Barbara A, Neus B, Tamara S, Manel J, Aleix P, Francesco S. Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study. Cancer Immunol Immunother 2023. [PMID: 36625938 DOI: 10.1007/s00262-022-03360-9] [Reference Citation Analysis]
3 Miyaguchi K, Wang H, Black KL, Shiao SL, Wang R, Yu JS. Activated T cell therapy targeting glioblastoma cancer stem cells. Sci Rep 2023;13:196. [PMID: 36604465 DOI: 10.1038/s41598-022-27184-w] [Reference Citation Analysis]
4 Gémes N, Makra Z, Neuperger P, Szabó E, Balog JÁ, Flink LB, Kari B, Hackler L, Puskás LG, Kanizsai I, Szebeni GJ. A cytotoxic survey on 2‐amino‐1H‐imidazol based synthetic marine sponge alkaloid analogues. Drug Development Research 2022. [DOI: 10.1002/ddr.22006] [Reference Citation Analysis]
5 Cui J, Xiong Y, Sun M, Gu X, Liu Y, Zhong L, Hong X, Liu L. Trends in immune-related adverse events for colorectal cancer: A bibliometric analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1024321] [Reference Citation Analysis]
6 Huang A, Groer C, Lu R, Forrest ML, Griffin JD, Berkland CJ. Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00730] [Reference Citation Analysis]
7 Alhaj-Suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Adv Drug Deliv Rev 2022;189:114482. [PMID: 35944587 DOI: 10.1016/j.addr.2022.114482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Xiong DD, Li JD, He RQ, Li MX, Pan YQ, He XL, Dang YW, Chen G. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Med 2022. [PMID: 36062845 DOI: 10.1002/cam4.5186] [Reference Citation Analysis]
9 Gollavelli G, Ghule AV, Ling Y. Multimodal Imaging and Phototherapy of Cancer and Bacterial Infection by Graphene and Related Nanocomposites. Molecules 2022;27:5588. [DOI: 10.3390/molecules27175588] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Lu F, Zhu Y, Zhang G, Liu Z. Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. Front Pharmacol 2022;13:944147. [DOI: 10.3389/fphar.2022.944147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu X, Lang Y, Chai Q, Lin Y, Liao Y, Zhu Y. Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis. Front Pharmacol 2022;13:872196. [DOI: 10.3389/fphar.2022.872196] [Reference Citation Analysis]
12 Davodabadi F, Sarhadi M, Arabpour J, Sargazi S, Rahdar A, Díez-Pascual AM. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. J Control Release 2022;349:844-75. [PMID: 35908621 DOI: 10.1016/j.jconrel.2022.07.036] [Reference Citation Analysis]
13 Isaac-Lam MF, DeMichael KM. Calorie restriction and breast cancer treatment: a mini-review. J Mol Med (Berl) 2022;100:1095-109. [PMID: 35760911 DOI: 10.1007/s00109-022-02226-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang W, Chen X, Li J, Jin Q, Jin HJ, Li X. Hollow MnO 2 Nanoparticles Loaded with Functional Genes as Nanovaccines for Synergistic Cancer Therapy. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01877] [Reference Citation Analysis]
15 Chen Y, Hua W, Hsu JC, Chang PS, Wen KK, Huang Y, Tsai J, Kao Y, Wu P, Wang P, Chen K, Liao W, Wu SC. Quantum CART (qCART), a piggyBac-based system for development and production of virus-free multiplex CAR-T cell therapy.. [DOI: 10.1101/2022.05.03.490469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hussain A. Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00238-8] [Reference Citation Analysis]
17 Abdullah EA. Theoretical study of a single-walled carbon nanotube and a cellulose biofiber as 5-fluorouracil anti-cancer drug carriers. Eur J Chem 2022;13:69-77. [DOI: 10.5155/eurjchem.13.1.69-77.2188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Park SC, Heo H, Jang MK. Polyethylenimine grafted-chitosan based Gambogic acid copolymers for targeting cancer cells overexpressing transferrin receptors. Carbohydr Polym 2022;277:118755. [PMID: 34893210 DOI: 10.1016/j.carbpol.2021.118755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li Y, Wang S, Chen L, Feng Y, Shen Z, Chen X, Huang G, Ni Y. Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies. Technol Cancer Res Treat 2022;21:153303382211367. [DOI: 10.1177/15330338221136716] [Reference Citation Analysis]
20 Canetta E. Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine. Int J Mol Sci 2021;22:13141. [PMID: 34884946 DOI: 10.3390/ijms222313141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Demirtürk N, Bilensoy E. Nanocarriers targeting the diseases of the pancreas. Eur J Pharm Biopharm 2021:S0939-6411(21)00337-4. [PMID: 34852262 DOI: 10.1016/j.ejpb.2021.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]